Thrombotic thrombocytopenic purpura epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
{{Thrombotic thrombocytopenic purpura}} | {{Thrombotic thrombocytopenic purpura}} | ||
{{CMG}} | {{CMG}} {AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== |
Revision as of 18:09, 13 August 2015
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Thrombotic thrombocytopenic purpura Microchapters |
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura epidemiology and demographics |
FDA on Thrombotic thrombocytopenic purpura epidemiology and demographics |
CDC on Thrombotic thrombocytopenic purpura epidemiology and demographics |
Thrombotic thrombocytopenic purpura epidemiology and demographics in the news |
Blogs on Thrombotic thrombocytopenic purpura epidemiology and demographics |
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] {AE}}Faizan Sheraz, M.D. [2]
Overview
Epidemiology and Demographics
The incidence of TTP is about 4-6 per million people per year. As with most other autoimmune disorders, idiopathic TTP occurs more often in women and African American population, while the secondary forms do not show this distribution.